Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis
1 other identifier
interventional
607
1 country
14
Brief Summary
This is a diagnostic accuracy study. Eligible individuals will be enrolled and asked to undergo ds-MCE and EGD examinations. EGD is the reference standard against which ds-MCE is compared, and it will be performed within 48 hours after ds-MCE examination. The primary outcome is the sensitivity and specificity of ds-MCE in identifying the presence of esophagogastric (EGV) in patients with cirrhosis, using detection by EGD as the reference. The diagnostic accuracy of ds-MCE in detection of high-risk EV, high-risk EGV, EV, large EV, red signs of EV, GV, cardiofundal GV and PHG compared with the EGD will also be assessed. The incidence of PHE in small bowel under ds-MCE, the examination time of ds-MCE and EGD procedures, patient satisfaction assessment and safety evaluation will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
Typical duration for not_applicable
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2018
CompletedFirst Posted
Study publicly available on registry
November 21, 2018
CompletedStudy Start
First participant enrolled
January 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2023
CompletedAugust 1, 2023
July 1, 2023
2 years
November 12, 2018
July 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the diagnostic accuracy of the ds-MCE in identifying the presence of esophagogastric varices (EGV)
the sensitivity and specificity of ds-MCE in identifying EGV in patients with cirrhosis, using the detection by EGD as the reference.
2 weeks
Secondary Outcomes (13)
the diagnostic accuracy of the ds-MCE in identifying the presence of esophageal varices (EV)
2 weeks
the diagnostic accuracy of the ds-MCE in identifying the red sign of EV
2 weeks
the diagnostic accuracy of the ds-MCE in differentiating large esophageal varices
2 weeks
the optimal esophageal luminal circumference percentage threshold under ds-MCE for distinguishing large EV
2 weeks
the diagnostic accuracy of the ds-MCE in differentiating high-risk esophageal varices
2 weeks
- +8 more secondary outcomes
Study Arms (1)
ds-MCE and EGD
EXPERIMENTALAll the enrolled participants will undergo the examination of detachable string magnetically maneuvered capsule endoscopy (ds-MCE) first, followed by EGD within 48 hours.
Interventions
Procedure of ds-MCE: The ds-MCE system mainly consists of two parts: the NaviCam magnetically maneuvered capsule endoscopy system and the detachable string part. The capsule, which is partially enclosed within the sleeve, can be actively moved in the esophagus through the control of string. Investigator can examine the entire esophagus several times under real time views. After completing the esophageal examination, the capsule could be detached from the string through injecting air into the hollow string with the syringe. Then, the examination of stomach under magnetic control and small bowel under the natural action of gastrointestinal peristalsis follows. Procedure of EGD: The esophagogastroduodenoscopy (EGD) will be performed using conventional upper gastrointestinal video endoscopy, according to the standard procedure at individual centers. EGD will be performed within 48 hours after ds-MCE procedure and usually during the same endoscopic session.
Eligibility Criteria
You may qualify if:
- Gender is not limited.
- Patients aged 18 years or older.
- Both inpatients and outpatients.
- Clinically evident or biopsy-proven liver cirrhosis.
- Able to provide informed consent.
You may not qualify if:
- Patients aged less than 18 years.
- Patients with Zenker's diverticulum.
- Patients with active gastrointestinal bleeding.
- Patients who have participated in or are participating in other clinical trials.
- Pregnancy or suspected pregnancy.
- Suspected or known intestinal stenosis or other known risk factors for capsule retention.
- Pacemaker or other implanted electromedical devices which could interfere with magnetic resonance.
- Patients with dysphagia.
- Life-threatening conditions.
- Patients plan to undergo magnetic resonance imaging examination before excretion of the MCE.
- Patients who refuse to give informed consent.
- Patients with any condition that precludes compliance with the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Changhai Hospitallead
- Ruijin Hospitalcollaborator
- Shanghai Tongji Hospital, Tongji University School of Medicinecollaborator
- Shanghai Jiao Tong University Affiliated Sixth People's Hospitalcollaborator
- Shanghai East Hospital of Tongji Universitycollaborator
- Yangpu District Central Hospital Affiliated to Tongji Universitycollaborator
- Zhujiang Hospitalcollaborator
- Qilu Hospital of Shandong Universitycollaborator
- The Third Xiangya Hospital of Central South Universitycollaborator
- First Affiliated Hospital Xi'an Jiaotong Universitycollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
- The Fifth Affiliated Hospital of Zunyi Medical Collegecollaborator
- The First Affiliated Hospital of Zhejiang Chinese Medical Universitycollaborator
- Shanghai Pudong New Area Gongli Hospitalcollaborator
Study Sites (14)
Zhujiang Hospital,Southern Medical University
Guangzhou, Guangdong, 510000, China
the Fifth Affiliated Hospital of Zunyi Medical University
Zhuhai, Guangdong, 519000, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410000, China
Qilu Hospital of Shandong University
Jinan, Shandong, 250000, China
Ruijin Hospital
Shanghai, Shanghai Municipality, 200000, China
Shanghai East Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, 200000, China
Shanghai Jiao Tong University affiliated Sixth people's Hospital
Shanghai, Shanghai Municipality, 200000, China
Shanghai Tongji Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, 200000, China
Shanghai Pudong New Area Gongli Hospital
Shanghai, Shanghai Municipality, 200135, China
Yangpu District Central Hospital Affiliated to Tongji University
Shanghai, Shanghai Municipality, 200433, China
First Affiliated Hospital Xi'an Jiaotong University
Xi’an, Shanxi, 710000, China
The First Affiliated Hospital of Zhejiang Chinese Medical University
Hanzhou, Zhejiang, 310000, China
Changhai Hospital
Shanghai, 200433, China
Related Publications (11)
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3. No abstract available.
PMID: 26047908BACKGROUNDNorth Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988 Oct 13;319(15):983-9. doi: 10.1056/NEJM198810133191505.
PMID: 3262200BACKGROUNDSpina GP, Arcidiacono R, Bosch J, Pagliaro L, Burroughs AK, Santambrogio R, Rossi A. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol. 1994 Sep;21(3):461-7. doi: 10.1016/s0168-8278(05)80329-0. No abstract available.
PMID: 7836719BACKGROUNDSarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992 Dec;16(6):1343-9. doi: 10.1002/hep.1840160607.
PMID: 1446890BACKGROUNDKodama M, Uto H, Numata M, Hori T, Murayama T, Sasaki F, Tsubouchi N, Ido A, Shimoda K, Tsubouchi H. Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy. J Gastroenterol. 2008;43(8):589-96. doi: 10.1007/s00535-008-2198-1. Epub 2008 Aug 17.
PMID: 18709480BACKGROUNDD'Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003 Sep;38(3):599-612. doi: 10.1053/jhep.2003.50385.
PMID: 12939586BACKGROUNDGarcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007 Sep;46(3):922-38. doi: 10.1002/hep.21907. No abstract available.
PMID: 17879356BACKGROUNDLapalus MG, Dumortier J, Fumex F, Roman S, Lot M, Prost B, Mion F, Ponchon T. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy. 2006 Jan;38(1):36-41. doi: 10.1055/s-2006-924975.
PMID: 16429353BACKGROUNDGralnek IM, Adler SN, Yassin K, Koslowsky B, Metzger Y, Eliakim R. Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2. Endoscopy. 2008 Apr;40(4):275-9. doi: 10.1055/s-2007-995645.
PMID: 18389444BACKGROUNDde Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J, Eliakim R. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008 May;47(5):1595-603. doi: 10.1002/hep.22227.
PMID: 18435461BACKGROUNDJiang X, Pan J, Xu Q, Song YH, Sun HH, Peng C, Qi XL, Qian YY, Zou WB, Yang Y, Jin SQ, Duan BS, Wu S, Chu Y, Xiao DH, Hu LJ, Cao JZ, Dai JF, Liu X, Xia T, Zhou W, Chen T, Zhou CH, Wu W, Liu SJ, Yang ZY, Wang F, Zhang L, Li CZ, Xu H, Wang JX, Wei B, Lin Y, Deng X, Qu LH, Shen YQ, Wang H, Huang YF, Bao HB, Zhang S, Li L, Shi YH, Wang XY, Zou DW, Wan XJ, Xu MD, Mao H, He CH, Li Z, Zuo XL, He SX, Xie XP, Liu J, Yang CQ, Spada C, Li ZS, Liao Z. Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study. BMJ. 2024 Mar 5;384:e078581. doi: 10.1136/bmj-2023-078581.
PMID: 38443074DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhuan Liao
Changhai Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 12, 2018
First Posted
November 21, 2018
Study Start
January 7, 2021
Primary Completion
January 10, 2023
Study Completion
March 6, 2023
Last Updated
August 1, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 3 years.
- Access Criteria
- The website of the journal where the results published, and ClinicalTrials.gov web site.
Data can be shared after publication of the main results.